October 1, 2024
The European Commission has approved the topical pan-JAK inhibitor delgocitinib for adults with moderate to severe hand eczema, for whom topical corticosteroids are inadequate or inappropriate, […]
September 30, 2024
AMSTERDAM — For patients with atopic dermatitis (AD) who responded to the anti-interleukin (IL)-13 monoclonal antibody lebrikizumab in the pivotal trials, the level of response, including […]
September 30, 2024
SAN DIEGO — Although it has been known for several years that more than 1000 species of bacteria from 19 different phyla inhabit the human skin […]
September 27, 2024
AMSTERDAM — There is a mountain of evidence that atopic dermatitis (AD) exerts a large negative impact on quality of life, but a unique study with […]
September 27, 2024
TOPLINE: Global antimicrobial susceptibility patterns of Staphylococcus aureus in atopic dermatitis (AD) highlight suboptimal effectiveness for several antibiotics, with significant differences between high-income and middle-income countries. […]
September 24, 2024
New York — The diagnosis of central centrifugal cicatricial alopecia (CCCA), the most common form of cicatrizing hair loss in Black women, is still being missed, […]
September 19, 2024
TOPLINE: Roflumilast cream 0.15% was well tolerated and significantly improved symptoms in adults and children with mild to moderate atopic dermatitis (AD) in two phase 3 […]
September 19, 2024
NEW YORK — Because of their heterogeneity in appearance, drug-induced skin rashes are a common diagnostic challenge, but eruptions in skin of color, particularly those with […]
September 18, 2024
TOPLINE: The prevalence of early onset of puberty was higher in children with hidradenitis suppurativa (HS) than those without HS, in a study that found precocious […]